Impact of Thrombus Burden on Outcomes After Standard Versus Mesh-Covered Stents in Acute Myocardial Infarction (from the MGuard for Acute ST Elevation Reperfusion Trial)

Nov 30, 2016 by in CARDIOLOGY Comments Off on Impact of Thrombus Burden on Outcomes After Standard Versus Mesh-Covered Stents in Acute Myocardial Infarction (from the MGuard for Acute ST Elevation Reperfusion Trial)

Large thrombus burden negatively affects the results of percutaneous coronary intervention (PCI) for acute ST-segment elevation myocardial infarction (STEMI). We investigated the impact of thrombus burden in patients with STEMI…

read more

Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention

Nov 30, 2016 by in CARDIOLOGY Comments Off on Impact of Lipoprotein(a) as Residual Risk on Long-Term Outcomes in Patients After Percutaneous Coronary Intervention

Cardiovascular risk remains uncertain in patients with cardiovascular disease despite achieving target lipid levels. Serum levels of lipoprotein(a) [Lp(a)] can be risk factors for adverse events. The aim of this…

read more

Meta-Analysis of Deferral Versus Performance of Coronary Intervention Based on Coronary Pressure–Derived Fractional Flow Reserve

Nov 30, 2016 by in CARDIOLOGY Comments Off on Meta-Analysis of Deferral Versus Performance of Coronary Intervention Based on Coronary Pressure–Derived Fractional Flow Reserve

Fractional flow reserve (FFR) has been proposed as the gold standard to assess functional severity of coronary artery stenosis and to stratify which lesions should be subjected to intervention (percutaneous…

read more

Contradictory Effects of Hypercholesterolemia and Diabetes Mellitus on the Progression of Abdominal Aortic Aneurysm

Nov 30, 2016 by in CARDIOLOGY Comments Off on Contradictory Effects of Hypercholesterolemia and Diabetes Mellitus on the Progression of Abdominal Aortic Aneurysm

Hypercholesterolemia and type 2 diabetes mellitus (DM) are well-established risk factors for atherosclerotic occlusive disease. However, of the 2, only the former is a risk factor for abdominal aortic aneurysm…

read more

Overview of the Food and Drug Administration Circulatory System Devices Panel Meetings on WATCHMAN Left Atrial Appendage Closure Therapy

Nov 30, 2016 by in CARDIOLOGY Comments Off on Overview of the Food and Drug Administration Circulatory System Devices Panel Meetings on WATCHMAN Left Atrial Appendage Closure Therapy

The WATCHMAN left atrial appendage closure (LAAC) technology is a percutaneously delivered permanent cardiac implant placed in the LAA. This device is designed to reduce the risk of stroke and…

read more

Fifteen-Year Experience With Carotid Artery Stenting (from the Carotid Artery Stenting—Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte)

Nov 30, 2016 by in CARDIOLOGY Comments Off on Fifteen-Year Experience With Carotid Artery Stenting (from the Carotid Artery Stenting—Registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte)

To date only sparse data are available on trends and changes in indications, patient’s characteristics, and clinical outcome of patients undergoing carotid artery stenting (CAS) in clinical practice. From February…

read more
Get Clinical Tree app for offline access